Medical Imaging AI in the FDA / CE Pipeline

Medical imaging is the most-cleared AI category in healthcare — over 700 FDA-cleared AI/ML-enabled medical devices, the majority in imaging. The clearance is not the deployment. Health systems run AI imaging tools that produce real clinical value; they also run tools that produce alert fatigue and skepticism. The difference is in the workflow integration, not the model.

What works in production medical imaging AI.

What the clearance actually means#

An FDA clearance (510(k), De Novo, or PMA) covers a specific intended use. The tool was tested against a specific benchmark in a specific way. It doesn’t mean:

• The tool generalizes to your patient population without verification
• The tool’s performance is independent of your scanner, protocol, reconstruction
• The tool’s workflow integration is appropriate for your environment

The radiology AI program that succeeds is the one that re-validates each tool against the local population before relying on it.

Where AI imaging earns its place#

Detection assistance for high-volume screenings. Mammography, lung CT screening, DR for retinal screening. AI as second reader or worklist prioritizer.

Triage and prioritization. Flag scans likely to contain critical findings (intracranial hemorrhage, pulmonary embolism, aortic dissection) for radiologist priority review.

Quantification. Lesion measurement, tumor volume tracking, cardiac function metrics. Better consistency than visual estimation.

Quality assurance. Detecting scanner artifacts, image-quality issues, missed coverage. Boring but valuable.

Workflow optimization. Hanging protocols, reporting templates, structured data extraction.

Where it doesn’t (yet) earn its place#

End-to-end autonomous reporting. Not in 2026. Maybe not for a long time.

Replacing the radiologist. Augmenting, accelerating, prioritizing — yes. Replacing — no.

Tools that produce alerts without clinical context. Alert fatigue kills the program; clinical context keeps it alive.

Tools that don’t integrate with PACS and reporting. Standalone tools don’t get used.

The integration question#

Imaging AI tools must integrate with:

• PACS (Sectra, GE, Philips, Visage, etc.)
• RIS (radiology information system)
• Reporting platforms (PowerScribe, Nuance, etc.)
• EHR
• AI orchestration platforms (Aidoc, Blackford, Sirona, Bayer Calantic) that abstract multi-vendor AI

The orchestration platforms have become a de-facto requirement at scale. Running 5+ AI tools without orchestration produces a fragmented experience that radiologists won’t use.

The post-market surveillance discipline#

FDA-cleared AI in imaging requires ongoing monitoring:

• Performance vs the clearance baseline
• Drift over time
• Adverse event tracking
• Re-training notifications when the vendor updates the model

Health systems running imaging AI need a program around surveillance, not just procurement.

What we ship for imaging programs#

For medical imaging AI engagements via our data engineering practice:

• Tool selection matched to the system’s clinical and operational needs
• Orchestration platform integration
• Local validation workflow before each tool goes live
• PACS/RIS/reporting integration
• Post-market surveillance program
• Radiologist workflow design with AI integrated

The economics#

A 10-radiologist practice runs typical AI orchestration cost of $40k–$150k/year all-in. The ROI math depends heavily on which tools, which scan volumes, and what value is captured (revenue from new lines, throughput from existing).

The deployments that capture real value have:

• 3–6 specific tools matched to high-volume scan types
• Clear radiologist workflow that includes AI output
• Quarterly performance review and tool optimization

The deployments that don’t have all of these struggle to justify the cost.

The wider context#

Medical imaging AI is the most mature clinical AI category. The lessons from imaging transfer to other clinical AI use cases — careful clinical validation, workflow integration, post-market surveillance.

The Hospital Management System angle: imaging AI’s outputs often need to flow into the broader HMS context for billing, care coordination, and quality reporting. Tools that stop at PACS leave value on the table.

---

Imaging AI earns its place when integrated, locally validated, and under continuous surveillance. Our team builds imaging AI programs for health systems. Tell us about the program.